← FDA Drug Approvals (Drugs@FDA)

TADALAFIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VKT PHARMA · Approved 2021-11-04

Drug application

FDA Application #

ANDA215556

Application type

Abbreviated New Drug Application (Generic)

Brand name

TADALAFIL

Generic name

TADALAFIL

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VKT PHARMA

Manufacturer

Burel Pharmaceuticals, LLC

First approval

2021-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown